EcoDrugPlus

Ribosomal Protein L18a

Ensembl ID : ENSHCOG00000006361
Gene Symbol: RPL18A
3 Cross references
367 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSHCOG00000017624
Gene Symbol: RPL19
3 Cross references
328 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSHCOG00000017908
Gene Symbol: RPL21
3 Cross references
784 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSHCOG00000014322
Gene Symbol: RPL22
3 Cross references
199 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSHCOG00000007663
Gene Symbol: RPL23
3 Cross references
240 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSHCOG00000007950
Gene Symbol: RPL23A
3 Cross references
872 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSHCOG00000004302
Gene Symbol: RPL24
3 Cross references
318 Possible Orthologues:

Ribosomal Protein L26 Like 1

Ensembl ID : ENSHCOG00000003784
Gene Symbol: RPL26L1
3 Cross references
477 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSHCOG00000007922
Gene Symbol: RPL27
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSHCOG00000016904
Gene Symbol: RPL27A
4 Cross references
514 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSHCOG00000003134
Gene Symbol: RPL28
3 Cross references
285 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSHCOG00000000478
Gene Symbol: RPL29
3 Cross references
496 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).